Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Rocuronium bromide formulations

A preparation and solvent technology, applied in the field of rocuronium bromide preparations, can solve problems such as damage, achieve sufficient stability, excellent practicability, and ensure stability

Pending Publication Date: 2022-05-31
MARUISHI PHARMACEUTICAL CO LTD
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] However, in the technique of this document, a sulfoalkyl ether-β-cyclodextrin derivative or a pharmaceutically acceptable salt thereof is required, and it has been reported that its use causes kidney damage, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Rocuronium bromide formulations
  • Rocuronium bromide formulations
  • Rocuronium bromide formulations

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0128] Rocuronium bromide (rocuronium bromide), 1M hydrochloric acid, and sodium chloride were added to water for injection to obtain a solution (preparation) at pH 3.0. The solution was passed through a filter (filter) with a pore size of 0.2 μm to perform filter sterilization.

[0129] In addition, in the solution, the concentration of rocuronium bromide is 10 mg / mL, the concentration of hydrogen chloride is 16.8 mM, the concentration of sodium chloride is 9 mg / mL, the concentration of the whole component is 1.96 mass %, and the concentration of hydrogen chloride and sodium chloride is 0.96 mass % .

[0130] In addition, the osmotic pressure ratio of the solution to physiological saline is about 1.

[0131] The obtained solution (preparation) was filled into a glass vial, subjected to high-temperature treatment (treatment with high-pressure steam at 121°C for 20 minutes), and then stored (preserved) at 60°C, and the pH and the value of analogue C were measured over time. g...

Embodiment 2

[0133] In the same manner as in Example 1 except that the high-temperature treatment was not performed in Example 1, pH and the production rate of analogue C were measured over time.

reference example 1

[0135] Except having used the solution obtained in the following manner in Example 1, it carried out similarly to Example 1, and measured pH and the production rate of analog C over time.

[0136] Rocuronium bromide (rocuronium bromide), glycine, 1M hydrochloric acid, and sodium chloride were added to water for injection to obtain a solution (preparation) at pH 3.0.

[0137] In addition, in the solution, the concentration of rocuronium bromide is 10 mg / mL, the concentration of glycine is 73 mM, the concentration of hydrogen chloride is 30 mM, the concentration of sodium chloride is 5 mg / mL, and the concentration of the whole component is 2.16% by mass. Glycine, hydrogen chloride and sodium chloride The concentration is 1.16% by mass.

[0138] In addition, the osmotic pressure ratio of the solution to physiological saline is about 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a novel rocuronium bromide preparation. The rocuronium bromide preparation contains rocuronium bromide, has a pH of 4 or less, and does not contain a buffering agent.

Description

technical field [0001] The invention relates to rocuronium bromide preparations and the like. Background technique [0002] Rocuronium bromide (rocuronium bromide) is known as an active ingredient of a muscle relaxant for anesthesia and the like (Non-Patent Document 1). [0003] This rocuronium bromide is relatively unstable to heat in aqueous solution, and its preservation and transportation take effort and cost. For example, ESLAX, which is known as a commercial product of rocuronium bromide preparation, is a preparation containing an acetate buffer and requires refrigeration at 2 to 8° C. to ensure stability (Non-Patent Document 1). [0004] Therefore, attempts are being made to improve the stability of rocuronium bromide in formulations. For example, WO2008 / 065142 (Patent Document 1) discloses a technique in which a sulfoalkyl ether-β-ring Dextrin derivatives, or pharmaceutically acceptable salts thereof, stabilize aqueous solutions. [0005] However, in the techniqu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/58A61K47/04A61K47/12A61K47/20A61P21/02A61P23/00
CPCA61K31/58A61K47/02A61K47/12A61K47/20A61P21/02A61P23/00
Inventor 王咏井辻裕
Owner MARUISHI PHARMACEUTICAL CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products